Prognostic analyses indicated that ccRCC patients with high TPM3P9 expression had shorter overall survival (OS) and relapse-free survival (RFS) (Fig. 2l, m). The gene discussed is TPM3P9; the disease is nonpapillary renal cell carcinoma.